Abstract: A stable oil-in-water emulsion suitable for parenteral administration, containing less than 10% by weight lecithin, consisting of an aqueous phase and of an oil phase which is very finely dispersed by means of a physiologically tolerated emulsifier and which contains at least one carotenoid and is based on a physiologically tolerated oil or fat and comprises as emulsifier polyoxyethylene/polyoxypropylene block polymers and/or lecithin, and wherein the carotenoid is present in the oil phase in a concentration above the saturation solubility of the carotenoid in the oil or fat at room temperature.

Abstract: Stable aqueous solubilizates are disclosed suitable for parenteral administration, of carotenoids and vitamins or vitamin derivatives, in which the carotenoid and the water-insoluble vitamins are, with the aid of a nonionic emulsifier, in the form of a micellar solution, the micelles being smaller than 100 nm, wherein the solubilizates comprise, in amounts based on the solubilizate, at least one carotenoid in a concentration of from 0.1 to 10% by weight, the water-insoluble, lipophilic vitamins or vitamin derivatives in a concentration of from 0.1 to 20% by weight and the nonionic emulsifiers in a concentration of from 1 to 40% by weight, with the proviso that the content of lipophilic vitamins is at least as large as that of the carotenoid.

Abstract: The use of carotenoids for producing drugs for the treatment of inflammatory disorders not caused by the action of light or an infection with microorganisms.

Abstract: Direct tabletting aidsA) 75-98% by weight of a powdered cellulose suitable for tablettingB) 1-15% by weight of soluble polyvinylpyrrolidoneC) 0.5-10% by weight of crosslinked insoluble polyvinylpyrrolidone.

Abstract: A cylindrical delayed release tablet with a convex or flat upper side and lower side is provided, along with a method for its production and a gelatin capsule containing 3-200 tablets of the same having identical or different release rates, wherein the tablet if made of .beta.-phenylpropiophenone derivatives of the formula I as active ingredient ##STR1## where R is n-propyl or 1,1-dimethylpropyl, and their pharmacologically acceptable salts, wherein the tablet has a height and diameter that are both, independently of one another, 1-3 mm, the active ingredient content is in the range from 81-99.